2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$347.41+$2.69 (+0.78%)
Price as of Jun 23, 2026 12:17 PM EDT- $186.0BMarket Cap
- 30.33%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$347.41+$2.69 (+0.78%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 35.1B +5.16% | 33.4B +18.57% | 28.2B +7.09% | 26.3B +1.32% | |
Cost of Revenue | 12.0B -6.39% | 12.9B +52.15% | 8.5B +31.92% | 6.4B -0.74% | |
Gross Profit | 23.1B +12.37% | 20.6B +4.19% | 19.7B -0.89% | 19.9B +2.01% | |
Sales and Marketing Expense | 7.0B -0.65% | 7.1B +14.84% | 6.2B +14.13% | 5.4B +0.86% | |
Research and Development Expense | -7.3B +21.93% | -6.0B +24.67% | -4.8B +7.89% | -4.4B -7.99% | |
Depreciation and Amortization Expense | 5.2B -7.60% | 5.6B +37.36% | 4.1B +19.14% | 3.4B +0.56% | |
Total Operating Expenses | 27.7B +5.75% | 26.2B +28.94% | 20.3B +21.10% | 16.8B -8.63% | |
Operating Profit | 9.1B +25.10% | 7.3B -8.09% | 7.9B -17.45% | 9.6B +25.23% | |
Interest Income | 408.0M -20.00% | 510.0M -57.50% | 1.2B N/A | N/A N/A | |
Interest Expense | -2.8B -12.68% | -3.2B +9.74% | -2.9B +104.48% | -1.4B +17.46% | |
Interest Income and Expense and Net | -2.3B -11.27% | -2.6B +57.91% | -1.7B +19.13% | -1.4B +17.46% | |
Total Nonoperating Income and Expense | 2.7B +423.91% | 506.0M -82.14% | 2.8B +448.03% | -814.0M -414.29% | |
Income before Taxes | 9.0B +94.75% | 4.6B -41.32% | 7.9B +6.93% | 7.3B +9.63% | |
Income Taxes | 1.3B +143.74% | 519.0M -54.39% | 1.1B +43.32% | 794.0M -1.73% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 7.7B +88.53% | 4.1B -39.11% | 6.7B +2.52% | 6.6B +11.18% | |
Net Income from Continuing Operations Applicable to Common | 9.0B +119.46% | 4.1B -39.11% | 6.7B +2.52% | 6.6B +11.18% | |
Basic EPS and Net Income | 14.33 +88.06% | 7.62 -39.33% | 12.56 +3.12% | 12.18 +17.79% | |
Diluted EPS and Net Income | 14.23 +88.23% | 7.56 -39.47% | 12.49 +3.14% | 12.11 +17.80% | |
Basic Weighted Average Shares | 538.0M +0.19% | 537.0M +0.37% | 535.0M -0.56% | 538.0M -5.61% | |
Diluted Weighted Average Shares | 542.0M +0.18% | 541.0M +0.56% | 538.0M -0.55% | 541.0M -5.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.1B -23.75% | 12.0B +9.40% | 10.9B +43.45% | 7.6B -4.51% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 1.7B +3,391.67% | |
Cash and Cash Equivalents and Short-Term Investments | 9.1B -23.75% | 12.0B +9.40% | 10.9B +17.61% | 9.3B +15.78% | |
Total Current Assets | 29.1B +0.09% | 29.0B -4.29% | 30.3B +36.72% | 22.2B +14.45% | |
Accumulated Depreciation | 11.1B +7.05% | 10.4B +5.91% | 9.8B +5.66% | 9.3B +5.51% | |
Property and Plant and Equipment and Net | 7.9B +20.94% | 6.5B +10.13% | 5.9B +9.47% | 5.4B +4.69% | |
Total Long-Term Assets | 12.7B +27.49% | 9.9B +3.32% | 9.6B +62.93% | 5.9B -9.58% | |
Total Assets | 90.6B -1.36% | 91.8B -5.47% | 97.2B +49.19% | 65.1B +6.47% | |
Income Taxes Payable | 1.4B -15.47% | 1.6B -31.35% | 2.4B +96.99% | 1.2B +70.47% | |
Total Short-Term Debt | 4.6B +29.55% | 3.5B +146.02% | 1.4B -9.30% | 1.6B +1,728.74% | |
Total Current Liabilities | 25.5B +10.35% | 23.1B +25.59% | 18.4B +17.24% | 15.7B +28.75% | |
Total Long-Term Debt | 50.0B -11.57% | 56.5B -10.48% | 63.2B +69.11% | 37.4B +12.44% | |
Total Long-Term Liabilities | 2.4B +1.23% | 2.3B +0.99% | 2.3B -12.62% | 2.7B +7.99% | |
Total Liabilities | 25.5B +10.35% | 23.1B +25.59% | 18.4B +17.24% | 15.7B +28.75% | |
Retained Earnings | -25.1B -9.00% | -27.6B +3.92% | -26.5B -7.24% | -28.6B +16.35% | |
Total Stockholders Equity | 8.7B +47.32% | 5.9B -5.70% | 6.2B +70.23% | 3.7B -45.36% | |
Total Shares Outstanding | 538.8M +0.35% | 536.9M +0.28% | 535.4M +0.26% | 534.0M -4.35% | |
Cash Flow | |||||
Cash from Operating Activities | 10.0B -13.33% | 11.5B +35.64% | 8.5B -12.86% | 9.7B +4.97% | |
Capital Expenditures | 1.9B +69.53% | 1.1B -1.44% | 1.1B +18.80% | 936.0M +6.36% | |
Cash from Investing Activities | -1.9B +85.76% | -1.0B -96.01% | -26.2B +333.55% | -6.0B -924.56% | |
Dividends Paid | 5.1B +6.04% | 4.8B +6.06% | 4.6B +8.58% | 4.2B +4.56% | |
Cash from Financing Activities | -10.9B +15.34% | -9.4B -144.73% | 21.0B +621.38% | -4.0B -51.19% | |
Financials Ratio | |||||
Gross Margin | 65.75% +6.86% | 61.53% -12.13% | 70.02% -7.46% | 75.66% +0.67% | |
Operating Margin | 25.83% +18.97% | 21.71% -22.48% | 28.01% -22.91% | 36.34% +23.59% | |
Return on Assets | 8.45% +95.32% | 4.33% -47.72% | 8.28% -20.22% | 10.38% +9.27% | |
Return on Equity | 106.10% +57.07% | 67.55% -50.25% | 135.79% +7.37% | 126.47% +72.86% | |
Revenue Growth | 5.16% -72.22% | 18.57% +161.77% | 7.09% +435.66% | 1.32% -39.34% | |
Current Ratio | 1.14 -9.29% | 1.26 -23.79% | 1.65 +16.61% | 1.41 -11.11% | |
Cash Ratio | 0.36 -30.89% | 0.52 -12.89% | 0.60 +22.35% | 0.49 -25.83% | |
Debt-to-Equity Ratio | 6.31 -38.33% | 10.23 -1.37% | 10.37 -2.54% | 10.64 +113.98% | |
Debt-to-Assets Ratio | 0.60 -7.89% | 0.65 -1.61% | 0.67 +11.22% | 0.60 +9.81% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow